UNSPSC 51284023: Demeclocycline hydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C21H21ClN2O8.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29O079NTYT, chemically known as 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride but more generally known as demeclocycline hydrochloride, which bears US NIH Compound Identifier 5281008.

UNSPSC 51284023 Demeclocycline hydrochloride is a Commodity code that names a specific tetracycline antibiotic formulation, but recent state and local procurement activity under this code shows no direct solicitations or awards for demeclocycline itself. Instead, the tagged opportunities reflect pharmaceutical procurement more broadly—Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a three-year term with renewal options, and Seminole County, Florida issued an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually. Neither solicitation involves demeclocycline or close tetracycline analogs. State and local procurement under this code does not appear to be active at present; the tagging of these opportunities suggests either misclassification in the underlying database or minimal real procurement demand for demeclocycline hydrochloride specifically.

The geographic activity centers on Florida and Illinois based on the two recorded opportunities, but the mismatch between the code's stated product and the actual solicitations limits confidence in geographic characterization. Illinois Department of Public Health's piggyback contract awarded in August 2026 represents a completed award rather than an open solicitation, while Seminole County's IFB posted in June 2026 with a July 26, 2023 due date (an apparent data error) represents the only recent active solicitation, though it addresses naloxone and deactivation systems rather than tetracyclines. Businesses evaluating pursuit under this code should verify directly with state and local procurement offices whether demeclocycline hydrochloride solicitations exist in their target geographies, as the current record suggests limited or no measurable market activity.